Real‐world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.

Autor: Peretz Soroka, Hagit1 (AUTHOR), Vora, Tushar2 (AUTHOR), Noujaim, Jonathan3 (AUTHOR), Marcoux, Nicolas4 (AUTHOR), Cohen‐Gogo, Sarah2 (AUTHOR), Alcindor, Thierry5 (AUTHOR), Holloway, Caroline6 (AUTHOR), Rodrigues, Caroline1 (AUTHOR), Karachiwala, Hatim7 (AUTHOR), Alvi, Saima8 (AUTHOR), Lee, Ursula9 (AUTHOR), Cheng, Sylvia10 (AUTHOR), Banerji, Shantanu11 (AUTHOR), Oberoi, Sapna11 (AUTHOR), Feng, Xiaolan9 (AUTHOR), Smrke, Alannah9 (AUTHOR), Simmons, Christine9 (AUTHOR), Razak, Albiruni Abdul1,12 (AUTHOR), Gupta, Abha A.1,2 (AUTHOR) abha.gupta@uhn.ca
Zdroj: Cancer Medicine. Sep2023, Vol. 12 Issue 18, p18872-18881. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje